3 Asian Growth Companies Insiders Favor With Up To 42% ROE

Simply Wall St · 1d ago

As Asian markets navigate a landscape marked by fluctuating economic momentum and geopolitical uncertainties, investors are increasingly focused on identifying resilient opportunities in the region. In this context, growth companies with high insider ownership stand out as potentially attractive investments, offering insights into management confidence and alignment with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In Asia

Name Insider Ownership Earnings Growth
Suzhou Dongshan Precision Manufacturing (SZSE:002384) 33.5% 75.2%
Seojin SystemLtd (KOSDAQ:A178320) 18% 110.8%
SEERS (KOSDAQ:A458870) 33.7% 39.7%
Ningbo Sanxing Medical ElectricLtd (SHSE:601567) 24.9% 45.6%
L&C BIOLTD (KOSDAQ:A290650) 24% 148.5%
Jiangxi Fushine Pharmaceutical (SZSE:300497) 21.1% 50.8%
HUMAN MADE (TSE:456A) 23.9% 29.2%
Great Microwave Technology (SHSE:688270) 29.5% 85.5%
Fulin Precision (SZSE:300432) 11.2% 60.7%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) 14.1% 41%

Click here to see the full list of 499 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Let's review some notable picks from our screened stocks.

ALTEOGEN (KOSDAQ:A196170)

Simply Wall St Growth Rating: ★★★★★★

Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩22.28 billion.

Operations: The company's revenue is derived from its biotechnology segment, which generated ₩203.76 million.

Insider Ownership: 25.3%

Return On Equity Forecast: 42% (2029 estimate)

Alteogen, with substantial insider ownership, is poised for robust growth in Asia. The company recently secured a US$365 million exclusive license agreement with a global pharmaceutical firm to develop and commercialize a subcutaneous biologic product using its ALT-B4 technology. Alteogen's revenue is forecasted to grow significantly faster than the Korean market at 43.8% annually, while earnings are expected to rise by 41.52% per year, indicating strong growth prospects despite recent share price volatility.

KOSDAQ:A196170 Earnings and Revenue Growth as at Aug 2026
KOSDAQ:A196170 Earnings and Revenue Growth as at Aug 2026

Sigenergy Technology (SEHK:6656)

Simply Wall St Growth Rating: ★★★★★★

Overview: Sigenergy Technology Co., Ltd specializes in developing and manufacturing energy storage systems, inverters, and smart energy solutions for various applications, with a market cap of HK$84.90 billion.

Operations: Sigenergy Technology Co., Ltd generates revenue primarily from its Batteries / Battery Systems segment, which amounts to CN¥9 billion.

Insider Ownership: 22%

Return On Equity Forecast: 34% (2028 estimate)

Sigenergy Technology, with significant insider ownership, is experiencing rapid growth in Asia. The company forecasts a substantial revenue increase of 240% to 270% for the first half of 2026, reaching RMB 9.5 billion to RMB 10 billion. Recent product launches like the SigenMate 2700 Ultra and strategic global expansions underscore its innovative edge in AI-driven energy solutions. Despite trading below estimated fair value, Sigenergy's earnings are expected to grow significantly at an annual rate of 32.7%.

SEHK:6656 Earnings and Revenue Growth as at Aug 2026
SEHK:6656 Earnings and Revenue Growth as at Aug 2026

Yushu Technology (SHSE:688836)

Simply Wall St Growth Rating: ★★★★★★

Overview: Yushu Technology Co., Ltd. focuses on the research, development, production, and sale of consumer- and industry-class general-purpose legged and humanoid robots, with a market cap of CN¥271.97 billion.

Operations: Yushu Technology Co., Ltd. generates revenue through its focus on consumer- and industry-class general-purpose legged and humanoid robots.

Insider Ownership: 21.4%

Return On Equity Forecast: 34% (2029 estimate)

Yushu Technology, with substantial insider ownership, recently completed a CNY 6.1 billion IPO, indicating strong market confidence. Despite a decline in net income to CNY 50.01 million for Q1 2026, revenue grew significantly year-on-year to CNY 422.84 million. The company's earnings are forecasted to grow at an impressive annual rate of over 76%, outpacing the Chinese market average and highlighting its robust growth potential amidst illiquid share conditions.

SHSE:688836 Earnings and Revenue Growth as at Aug 2026
SHSE:688836 Earnings and Revenue Growth as at Aug 2026

Make It Happen

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.